Comments for VITA - Stockpickr! Your Source for Stock Ideas

Comments for VITA

Added By	Comments	Type	Date Added
dougep	awaiting fda approval on major product, favorable industry segment, management team	Love	October 06, 2008
supratrade	SELL	Love	August 23, 2007
barrons2	From Barron's 8-11-07: Buy - Price 3.05 on August 7 by Think Equity 2Q07 shows that Orthovita is improving its foundation to better capitalize on projected second-half '08 launch of Cortoss [synthetic bone filler] into the vertebral-compression-fracture marketplace. We think the current cash balance should get the company to the launch, and that ongoing hires and growth in the base business will provide an excellent foundation. Reiterate Buy and 4.50 target.	Love	August 11, 2007
Barrons	Orthovita (VITA) Angiotech Pharmaceuticals (ANPI) sold all of the 5.68 million shares it owned on March 27. No details of the transaction were disclosed.	Hate	April 07, 2007